questionsmedicales.fr
Facteurs biologiques
Antigènes
Antigènes de surface
Molécules d'adhérence cellulaire
Molécule-1 d'adhérence des cellules vasculaires
Molécule-1 d'adhérence des cellules vasculaires : Questions médicales fréquentes
Diagnostic
5
Protéines d'adhérence
Tests sanguins
Immunohistochimie
Dosage ELISA
Maladies cardiovasculaires
Inflammation
Plasma
Protéines d'adhérence
Inflammation
Risque cardiovasculaire
Symptômes
5
Maladies auto-immunes
Maladies cardiovasculaires
Circulation sanguine
Obstruction vasculaire
Symptômes
Tests diagnostiques
Inflammation
Protéines d'adhérence
Prévention
5
Prévention
Mode de vie sain
Tabagisme
Risque cardiovasculaire
Stress
Protéines d'adhérence
Hydratation
Santé vasculaire
Examens médicaux
Prévention
Traitements
5
Thérapies anti-inflammatoires
Inhibiteurs
Médicaments
Protéines d'adhérence
Antioxydants
Acides gras oméga-3
Alimentation
Exercice physique
Efficacité des traitements
Conditions sous-jacentes
Complications
5
Complications
Maladies cardiovasculaires
Maladies auto-immunes
Symptômes
Santé cardiaque
Protéines d'adhérence
Facteurs de risque
5
Âge
Protéines d'adhérence
Stress chronique
Protéines d'adhérence
Alimentation
Graisses saturées
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Molécule-1 d'adhérence des cellules vasculaires : Questions médicales les plus fréquentes",
"headline": "Molécule-1 d'adhérence des cellules vasculaires : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Molécule-1 d'adhérence des cellules vasculaires : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-09",
"dateModified": "2025-12-30",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Molécule-1 d'adhérence des cellules vasculaires"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Molécules d'adhérence cellulaire",
"url": "https://questionsmedicales.fr/mesh/D015815",
"about": {
"@type": "MedicalCondition",
"name": "Molécules d'adhérence cellulaire",
"code": {
"@type": "MedicalCode",
"code": "D015815",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.050.301.350"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Molécule-1 d'adhérence des cellules vasculaires",
"alternateName": "Vascular Cell Adhesion Molecule-1",
"code": {
"@type": "MedicalCode",
"code": "D019010",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Florian Kleefeldt",
"url": "https://questionsmedicales.fr/author/Florian%20Kleefeldt",
"affiliation": {
"@type": "Organization",
"name": "Institute of Anatomy and Cell Biology, Julius-Maximilians-University Würzburg, Würzburg, Germany."
}
},
{
"@type": "Person",
"name": "Uwe Rueckschloss",
"url": "https://questionsmedicales.fr/author/Uwe%20Rueckschloss",
"affiliation": {
"@type": "Organization",
"name": "Institute of Anatomy and Cell Biology, Julius-Maximilians-University Würzburg, Würzburg, Germany."
}
},
{
"@type": "Person",
"name": "Süleyman Ergün",
"url": "https://questionsmedicales.fr/author/S%C3%BCleyman%20Erg%C3%BCn",
"affiliation": {
"@type": "Organization",
"name": "Institute of Anatomy and Cell Biology, Julius-Maximilians-University Würzburg, Würzburg, Germany."
}
},
{
"@type": "Person",
"name": "Man Hagiyama",
"url": "https://questionsmedicales.fr/author/Man%20Hagiyama",
"affiliation": {
"@type": "Organization",
"name": "Department of Pathology, Kindai University Faculty of Medicine, 377-2 Ohno-higashi, Osaka-sayama, Osaka 589-8511, Japan."
}
},
{
"@type": "Person",
"name": "Azusa Yoneshige",
"url": "https://questionsmedicales.fr/author/Azusa%20Yoneshige",
"affiliation": {
"@type": "Organization",
"name": "Department of Pathology, Kindai University Faculty of Medicine, 377-2 Ohno-higashi, Osaka-sayama, Osaka 589-8511, Japan."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "The effect of eight weeks combined training with omega-3 supplementation on the levels of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in older women.",
"datePublished": "2024-03-21",
"url": "https://questionsmedicales.fr/article/38777428",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.clnesp.2024.03.018"
}
},
{
"@type": "ScholarlyArticle",
"name": "Low brain-derived neurotrophic factor and high vascular cell adhesion molecule-1 levels are associated with chronic kidney disease in patients with type 2 diabetes mellitus.",
"datePublished": "2024-09-17",
"url": "https://questionsmedicales.fr/article/39355615",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fendo.2024.1403717"
}
},
{
"@type": "ScholarlyArticle",
"name": "Soluble Vascular Adhesion Protein 1 (sVAP-1) as a biomarker for pregnancy complications: A pilot study.",
"datePublished": "2023-05-30",
"url": "https://questionsmedicales.fr/article/37253043",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0284412"
}
},
{
"@type": "ScholarlyArticle",
"name": "Immunohistochemical Analysis of Adhesion Molecules E-Selectin, Intercellular Adhesion Molecule-1, and Vascular Cell Adhesion Molecule-1 in Inflammatory Lesions of Atopic Dermatitis.",
"datePublished": "2023-04-02",
"url": "https://questionsmedicales.fr/article/37109462",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/life13040933"
}
},
{
"@type": "ScholarlyArticle",
"name": "Associations of Circulating Vascular Cell Adhesion Molecule-1 and Intercellular Adhesion Molecule-1 With Long-Term Cardiac Function.",
"datePublished": "2024-03-18",
"url": "https://questionsmedicales.fr/article/38497480",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1161/JAHA.123.032213"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Facteurs biologiques",
"item": "https://questionsmedicales.fr/mesh/D001685"
},
{
"@type": "ListItem",
"position": 3,
"name": "Antigènes",
"item": "https://questionsmedicales.fr/mesh/D000941"
},
{
"@type": "ListItem",
"position": 4,
"name": "Antigènes de surface",
"item": "https://questionsmedicales.fr/mesh/D000954"
},
{
"@type": "ListItem",
"position": 5,
"name": "Molécules d'adhérence cellulaire",
"item": "https://questionsmedicales.fr/mesh/D015815"
},
{
"@type": "ListItem",
"position": 6,
"name": "Molécule-1 d'adhérence des cellules vasculaires",
"item": "https://questionsmedicales.fr/mesh/D019010"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Molécule-1 d'adhérence des cellules vasculaires - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Molécule-1 d'adhérence des cellules vasculaires",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-02-06",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Molécule-1 d'adhérence des cellules vasculaires",
"description": "Comment diagnostiquer une élévation de VCAM-1 ?\nQuels examens sont utilisés pour évaluer VCAM-1 ?\nVCAM-1 est-il un marqueur de maladies ?\nPeut-on mesurer VCAM-1 dans le plasma ?\nQuel rôle joue VCAM-1 dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D019010#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Molécule-1 d'adhérence des cellules vasculaires",
"description": "Quels symptômes sont liés à une élévation de VCAM-1 ?\nVCAM-1 est-il associé à des symptômes spécifiques ?\nComment VCAM-1 affecte-t-il la circulation ?\nLes symptômes de VCAM-1 sont-ils visibles ?\nVCAM-1 influence-t-il l'inflammation ?",
"url": "https://questionsmedicales.fr/mesh/D019010#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Molécule-1 d'adhérence des cellules vasculaires",
"description": "Comment prévenir l'élévation de VCAM-1 ?\nLe tabagisme influence-t-il VCAM-1 ?\nLe stress affecte-t-il VCAM-1 ?\nUne bonne hydratation aide-t-elle VCAM-1 ?\nLes examens réguliers aident-ils à prévenir les problèmes de VCAM-1 ?",
"url": "https://questionsmedicales.fr/mesh/D019010#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Molécule-1 d'adhérence des cellules vasculaires",
"description": "Quels traitements ciblent VCAM-1 ?\nVCAM-1 peut-il être traité par des médicaments ?\nY a-t-il des traitements naturels pour VCAM-1 ?\nLes changements de mode de vie aident-ils VCAM-1 ?\nLes traitements sont-ils efficaces contre VCAM-1 ?",
"url": "https://questionsmedicales.fr/mesh/D019010#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Molécule-1 d'adhérence des cellules vasculaires",
"description": "Quelles complications sont liées à VCAM-1 ?\nVCAM-1 peut-il entraîner des AVC ?\nComment VCAM-1 affecte-t-il le diabète ?\nLes maladies auto-immunes sont-elles liées à VCAM-1 ?\nVCAM-1 influence-t-il la santé cardiaque ?",
"url": "https://questionsmedicales.fr/mesh/D019010#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Molécule-1 d'adhérence des cellules vasculaires",
"description": "Quels sont les facteurs de risque pour VCAM-1 ?\nL'âge influence-t-il VCAM-1 ?\nLe manque d'exercice affecte-t-il VCAM-1 ?\nLe stress chronique est-il un facteur de risque ?\nUne alimentation riche en graisses influence-t-elle VCAM-1 ?",
"url": "https://questionsmedicales.fr/mesh/D019010#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une élévation de VCAM-1 ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins mesurant les niveaux de VCAM-1 peuvent être effectués."
}
},
{
"@type": "Question",
"name": "Quels examens sont utilisés pour évaluer VCAM-1 ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'immunohistochimie et les dosages ELISA sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "VCAM-1 est-il un marqueur de maladies ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il est associé à des maladies inflammatoires et cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Peut-on mesurer VCAM-1 dans le plasma ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les niveaux de VCAM-1 peuvent être mesurés dans le plasma sanguin."
}
},
{
"@type": "Question",
"name": "Quel rôle joue VCAM-1 dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "VCAM-1 aide à évaluer l'inflammation et le risque cardiovasculaire."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à une élévation de VCAM-1 ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent inflammation, douleur et troubles circulatoires."
}
},
{
"@type": "Question",
"name": "VCAM-1 est-il associé à des symptômes spécifiques ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est souvent lié à des symptômes de maladies cardiovasculaires et auto-immunes."
}
},
{
"@type": "Question",
"name": "Comment VCAM-1 affecte-t-il la circulation ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une élévation de VCAM-1 peut entraîner une obstruction vasculaire et des douleurs."
}
},
{
"@type": "Question",
"name": "Les symptômes de VCAM-1 sont-ils visibles ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les symptômes sont souvent internes et nécessitent des tests pour être détectés."
}
},
{
"@type": "Question",
"name": "VCAM-1 influence-t-il l'inflammation ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, VCAM-1 joue un rôle clé dans le processus inflammatoire."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'élévation de VCAM-1 ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir un mode de vie sain, avec une alimentation équilibrée et de l'exercice."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il VCAM-1 ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme augmente les niveaux de VCAM-1 et le risque cardiovasculaire."
}
},
{
"@type": "Question",
"name": "Le stress affecte-t-il VCAM-1 ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut augmenter l'expression de VCAM-1."
}
},
{
"@type": "Question",
"name": "Une bonne hydratation aide-t-elle VCAM-1 ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une bonne hydratation peut soutenir la santé vasculaire et réduire l'inflammation."
}
},
{
"@type": "Question",
"name": "Les examens réguliers aident-ils à prévenir les problèmes de VCAM-1 ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des examens réguliers peuvent détecter des anomalies tôt et prévenir des complications."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent VCAM-1 ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des thérapies anti-inflammatoires et des inhibiteurs de VCAM-1 sont explorés."
}
},
{
"@type": "Question",
"name": "VCAM-1 peut-il être traité par des médicaments ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments visent à réduire l'expression de VCAM-1."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements naturels pour VCAM-1 ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antioxydants et des acides gras oméga-3 peuvent aider à réduire VCAM-1."
}
},
{
"@type": "Question",
"name": "Les changements de mode de vie aident-ils VCAM-1 ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation saine et l'exercice peuvent réduire les niveaux de VCAM-1."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils efficaces contre VCAM-1 ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité varie selon les individus et les conditions sous-jacentes."
}
},
{
"@type": "Question",
"name": "Quelles complications sont liées à VCAM-1 ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent les maladies cardiovasculaires et les troubles inflammatoires."
}
},
{
"@type": "Question",
"name": "VCAM-1 peut-il entraîner des AVC ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une élévation de VCAM-1 est associée à un risque accru d'AVC."
}
},
{
"@type": "Question",
"name": "Comment VCAM-1 affecte-t-il le diabète ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "VCAM-1 est impliqué dans l'inflammation associée au diabète de type 2."
}
},
{
"@type": "Question",
"name": "Les maladies auto-immunes sont-elles liées à VCAM-1 ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, VCAM-1 est souvent élevé dans les maladies auto-immunes, aggravant les symptômes."
}
},
{
"@type": "Question",
"name": "VCAM-1 influence-t-il la santé cardiaque ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux élevés de VCAM-1 sont liés à une mauvaise santé cardiaque."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour VCAM-1 ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'obésité, le tabagisme et le diabète."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il VCAM-1 ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vieillissement est associé à une augmentation des niveaux de VCAM-1."
}
},
{
"@type": "Question",
"name": "Le manque d'exercice affecte-t-il VCAM-1 ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire peut augmenter les niveaux de VCAM-1."
}
},
{
"@type": "Question",
"name": "Le stress chronique est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut contribuer à l'élévation de VCAM-1."
}
},
{
"@type": "Question",
"name": "Une alimentation riche en graisses influence-t-elle VCAM-1 ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en graisses saturées peut augmenter VCAM-1."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 30/12/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Institute of Anatomy and Cell Biology, Julius-Maximilians-University Würzburg, Würzburg, Germany.
Publications dans "Molécule-1 d'adhérence des cellules vasculaires" :
3 publications dans cette catégorie
Affiliations :
Institute of Anatomy and Cell Biology, Julius-Maximilians-University Würzburg, Würzburg, Germany.
Publications dans "Molécule-1 d'adhérence des cellules vasculaires" :
3 publications dans cette catégorie
Affiliations :
Institute of Anatomy and Cell Biology, Julius-Maximilians-University Würzburg, Würzburg, Germany.
Publications dans "Molécule-1 d'adhérence des cellules vasculaires" :
3 publications dans cette catégorie
Affiliations :
Department of Pathology, Kindai University Faculty of Medicine, 377-2 Ohno-higashi, Osaka-sayama, Osaka 589-8511, Japan.
Publications dans "Molécule-1 d'adhérence des cellules vasculaires" :
3 publications dans cette catégorie
Affiliations :
Department of Pathology, Kindai University Faculty of Medicine, 377-2 Ohno-higashi, Osaka-sayama, Osaka 589-8511, Japan.
Publications dans "Molécule-1 d'adhérence des cellules vasculaires" :
3 publications dans cette catégorie
Affiliations :
Department of Pathology, Kindai University Faculty of Medicine, 377-2 Ohno-higashi, Osaka-sayama, Osaka 589-8511, Japan.
Publications dans "Molécule-1 d'adhérence des cellules vasculaires" :
3 publications dans cette catégorie
Affiliations :
Department of Pathology, Kindai University Faculty of Medicine, 377-2 Ohno-higashi, Osaka-sayama, Osaka 589-8511, Japan.
Publications dans "Molécule-1 d'adhérence des cellules vasculaires" :
2 publications dans cette catégorie
Affiliations :
Department of Quantitative Health Sciences Mayo Clinic Rochester MN.
Publications dans "Molécule-1 d'adhérence des cellules vasculaires" :
2 publications dans cette catégorie
Affiliations :
Department of Quantitative Health Sciences Mayo Clinic Rochester MN.
Publications dans "Molécule-1 d'adhérence des cellules vasculaires" :
2 publications dans cette catégorie
Affiliations :
Division of Cardiology, Department of Medicine Northwestern University Feinberg School of Medicine Chicago IL.
Department of Preventive Medicine Northwestern University Feinberg School of Medicine Chicago IL.
Publications dans "Molécule-1 d'adhérence des cellules vasculaires" :
2 publications dans cette catégorie
Affiliations :
Division of Cardiology, Department of Medicine Northwestern University Feinberg School of Medicine Chicago IL.
Department of Preventive Medicine Northwestern University Feinberg School of Medicine Chicago IL.
Publications dans "Molécule-1 d'adhérence des cellules vasculaires" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmacy, University of Genova, viale Cembrano 4, 16148 Genova, Italy.
Publications dans "Molécule-1 d'adhérence des cellules vasculaires" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmacy, University of Genova, viale Cembrano 4, 16148 Genova, Italy.
Publications dans "Molécule-1 d'adhérence des cellules vasculaires" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmacy, University of Genova, viale Cembrano 4, 16148 Genova, Italy.
Publications dans "Molécule-1 d'adhérence des cellules vasculaires" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmacy, University of Genova, viale Cembrano 4, 16148 Genova, Italy.
Publications dans "Molécule-1 d'adhérence des cellules vasculaires" :
2 publications dans cette catégorie
Affiliations :
Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, United States.
Publications dans "Molécule-1 d'adhérence des cellules vasculaires" :
2 publications dans cette catégorie
Affiliations :
Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Osaka, Japan.
Publications dans "Molécule-1 d'adhérence des cellules vasculaires" :
2 publications dans cette catégorie
Affiliations :
Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, United States.
Publications dans "Molécule-1 d'adhérence des cellules vasculaires" :
2 publications dans cette catégorie
Affiliations :
Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, United States.
Division of Pediatric Gastroenterology, Mayo Clinic, Rochester, MN, United States.
Publications dans "Molécule-1 d'adhérence des cellules vasculaires" :
2 publications dans cette catégorie
Affiliations :
Cardiovascular Molecular Imaging, Department of Biomedicine, University of Basel, Basel, Switzerland.
Publications dans "Molécule-1 d'adhérence des cellules vasculaires" :
Elevated levels of ICAM-1 and VCAM-1 are significant risk factors for cardiovascular diseases. Conversely, the regulatory roles of physical activity and omega-3 supplementation in these factors have b...
Forty elderly women, averaging 66.7 ± 4.13 years, were randomly assigned to four groups: placebo, omega-3 supplement, training, and training + omega-3. The combined exercise training program was imple...
ICAM-1 and VCAM-1 levels significantly decreased in the training and training + omega-3 groups (p < 0.001). The decrease in ICAM-1 within the training + omega-3 group was also significant compared to ...
The present study's results indicate that omega-3 supplementation can enhance the effectiveness of combined training in regulating cardiovascular risk factors....
Patients with type 2 diabetes mellitus (DM) have a high prevalence of chronic kidney disease (CKD). Energy imbalance and inflammation may be involved in the pathogenesis of CKD. We examined the effect...
Patients with type 2 DM were enrolled for this cross-sectional study. Fasting serum was prepared to measure the BDNF and VCAM-1 levels. An estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m...
Of the 548 enrolled participants, 156 had CKD. Patients with CKD exhibited significantly lower BDNF (median of 21.4 ng/mL, interquartile range [IQR]: 17.0-27.0 ng/mL vs. median of 25.9 ng/mL, IQR: 21....
CKD in patients with type 2 DM is associated with low serum BDNF and high VCAM-1 levels. BDNF and VCAM-1 have a synergistic effect on CKD. Thus, BDNF and VCAM-1 can be potential biomarkers for CKD ris...
Vascular adhesion protein 1 (VAP-1) has been implicated in a wide range of clinical conditions. Moreover, serum levels are associated with disease prediction and progression in several clinical studie...
We conducted a pilot study in a cohort of pregnant women (gestational week lower than 20 at the time of recruitment) attending their first antenatal ultrasound scan at the Leicester Royal Infirmary (L...
From July and October 2021, a total of 91 participants were enrolled. Using ELISA (enzyme-linked immunosorbent assay), we found reduced serum levels of sVAP-1 in pregnant women with either pregnancy i...
Further studies are needed to establish whether or not sVAP-1 might be considered as an early, non-invasive, and affordable biomarker to screen women who will develop PIH or GDM. Our data will aid sam...
E-selectin, ICAM-1 (intercellular adhesion molecule-1), and VCAM-1 (vascular cell adhesion molecule-1) play a role in atopic dermatitis (AD). This study aimed to evaluate their expression in skin biop...
Although VCAM-1 (vascular cell adhesion molecule-1) and ICAM-1 (intercellular adhesion molecule-1) have been associated with incident heart failure with preserved ejection fraction (HFpEF) and atrial ...
In MESA (Multi-Ethnic Study of Atherosclerosis), we evaluated the associations of circulating VCAM-1 and ICAM-1 at examination 2 (2002-2004) with measures of cardiac structure/function on cardiac magn...
Higher VCAM-1 and ICAM-1 were associated with lower LA function and left ventricular systolic function but were not associated with myocardial scar or interstitial fibrosis. VCAM-1 and ICAM-1 may prom...
The interaction between leukocytes and cytokine-activated retinal endothelium is an initiating step in non-infectious uveitis involving the posterior eye, mediated by cell adhesion molecules. However,...
Cervical cancer is a significant global health burden, and individualized treatment approaches are necessary due to its heterogeneity. Radiotherapy is a common treatment modality; however, the respons...
A cohort of 189 patients with stage IB2-IVA cervical cancer, treated with radiotherapy alone or concurrent chemoradiotherapy, was included. Serum samples were collected before treatment, and intercell...
The analysis of clinicopathological characteristics showed that age, family history of cervical cancer and post-menopausal status did not significantly differ between RS and RR groups. Tumor size demo...
Serum ICAM-1 and VCAM-1 levels show potential as predictive biomarkers for radiotherapy sensitivity in cervical cancer....
Endothelial dysfunction plays a key role in the development of liver cirrhosis. Among the biomarkers of endothelial dysfunction, the soluble form of Vascular Adhesion Protein-1 (sVAP-1) is an unconven...
Acute appendicitis is a common abdominal emergency observed in emergency departments (ED). Distinguishing between uncomplicated and complicated appendicitis is important in determining a treatment str...
Pediatric patients with suspected appendicitis admitted to the ED were enrolled in this prospective study. Pre-surgical serum VCAM-1 was tested in children with acute appendicitis within 72 h of sympt...
Among the 226 pediatric appendicitis patients, 70 had uncomplicated appendicitis, 138 had complicated appendicitis, and 18 had normal appendices. The mean serum VCAM-1 levels in patients with perforat...
Serum VCAM-1 levels may be helpful in differentiating uncomplicated and complicated appendicitis in children and could predict appendiceal perforation....
Chronic hyperglycemia induces pathogenic changes in the vascular endothelium and leads to the development of microvascular complications in patients with type 2 diabetes mellitus. Early identification...
This follow-up study was conducted in type 2 diabetic cohort aged between 30-70 years. Out of 160 eligible participants, 70 of them completed follow-up. Levels of cell adhesion molecules and selectins...
During the follow-up (2 years, median), 31 (44.3%) developed diabetic neuropathy, 10 (14.3%) developed diabetic retinopathy and, 27 (38.6%) developed diabetic nephropathy. A significant difference in ...
Cell adhesion molecules and selectins are indicators of microvascular complication among patients with type 2 diabetes (T2D). Association of these markers with the development of microvascular complic...